Literature DB >> 21774667

Laparoscopic adrenalectomy for metachronous metastases after ipsilateral nephrectomy for renal-cell carcinoma.

E Jason Abel1, Jose A Karam, Alonso Carrasco, Surena F Matin.   

Abstract

BACKGROUND AND
PURPOSE: While laparoscopic adrenalectomy (LA) is considered the standard of care for removal of small adrenal masses, there are minimal data describing the feasibility and outcomes of LA after previous ipsilateral nephrectomy (PIN). The purpose of the study was to describe the perioperative outcomes in a series of patients who were undergoing LA after PIN. PATIENTS AND METHODS: Using an institutional database, we identified patients who underwent LA since 2002 by a single surgeon. Clinical and pathologic data were collected and analyzed. To evaluate outcomes, patients undergoing LA after PIN were compared with patients undergoing LA without PIN.
RESULTS: Of 54 consecutive patients undergoing LA, 8 had PIN for renal-cell carcinoma (RCC). Estimated blood loss was not significantly greater in patients with PIN: 50 mL vs 100 mL, P=0.109. Operative time was longer in patients with PIN: 120 minutes vs 156 minutes, P=0.015. There was no difference in length of hospital stay between groups: Median 2 days for both groups, P=0.635. One patient in the PIN group had a conversion to open adrenalectomy and needed blood transfusion. Perioperative complications were seen in 5/46 (10.6%) patients without and in 1/8 (12.5%) patients with PIN. Surgical margins were negative in all patients.
CONCLUSIONS: To the authors' knowledge, this study represents the largest experience with adrenalectomy in the reoperative setting. LA after PIN is associated with a longer operative time. While the potential for conversion is possible, it is technically feasible in selected patients and thus far appears to be associated with similar perioperative outcomes compared with patients without PIN.

Entities:  

Mesh:

Year:  2011        PMID: 21774667      PMCID: PMC3148128          DOI: 10.1089/end.2011.0066

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  22 in total

Review 1.  The necessity of adrenalectomy at the time of radical nephrectomy: a systematic review.

Authors:  Rebecca L O'Malley; Guilherme Godoy; Jamie A Kanofsky; Samir S Taneja
Journal:  J Urol       Date:  2009-03-14       Impact factor: 7.450

2.  Radio-frequency ablation of solitary adrenal gland metastasis from renal cell carcinoma.

Authors:  Pascal Mouracade; Herve Dettloff; Marc Schneider; Bertrand Debras; Jean-Luc Jung
Journal:  Urology       Date:  2009-09-25       Impact factor: 2.649

3.  Laparoscopic resection of local recurrence after previous radical nephrectomy for clinically localized renal-cell carcinoma: perioperative outcomes and initial observations.

Authors:  Jithin Yohannan; Tom Feng; Jared Berkowitz; Stephen S Connolly; Philip Pierorazio; Mohamad E Allaf
Journal:  J Endourol       Date:  2010-10       Impact factor: 2.942

4.  Laparoscopic adrenalectomy: the optimal surgical approach.

Authors:  E Kebebew; A E Siperstein; Q Y Duh
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2001-12       Impact factor: 1.878

5.  Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy.

Authors:  N B Itano; M L Blute; B Spotts; H Zincke
Journal:  J Urol       Date:  2000-08       Impact factor: 7.450

Review 6.  Isolated local recurrence of renal cell carcinoma after radical nephrectomy: experience with 10 cases.

Authors:  Cağatay Göğüş; Sümer Baltaci; Yaşar Bedük; Savaş Sahinli; Sadettin Küpeli; Orhan Göğüş
Journal:  Urology       Date:  2003-05       Impact factor: 2.649

7.  Ultrasound-guided percutaneous microwave ablation of adrenal metastasis: preliminary results.

Authors:  Yang Wang; Ping Liang; Xiaoling Yu; Zhigang Cheng; Jie Yu; Jun Dong
Journal:  Int J Hyperthermia       Date:  2009       Impact factor: 3.914

8.  Open and laparoscopic adrenalectomy: analysis of the National Surgical Quality Improvement Program.

Authors:  James Lee; Mahmoud El-Tamer; Tracy Schifftner; Florence E Turrentine; William G Henderson; Shukri Khuri; John B Hanks; William B Inabnet
Journal:  J Am Coll Surg       Date:  2008-03-24       Impact factor: 6.113

9.  Surgical morbidity associated with administration of targeted molecular therapies before cytoreductive nephrectomy or resection of locally recurrent renal cell carcinoma.

Authors:  Vitaly Margulis; Surena F Matin; Nizar Tannir; Pheroze Tamboli; David A Swanson; Eric Jonasch; Christopher G Wood
Journal:  J Urol       Date:  2008-05-15       Impact factor: 7.450

10.  Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study.

Authors:  Daniel Y C Heng; Wanling Xie; Meredith M Regan; Mark A Warren; Ali Reza Golshayan; Chakshu Sahi; Bernhard J Eigl; J Dean Ruether; Tina Cheng; Scott North; Peter Venner; Jennifer J Knox; Kim N Chi; Christian Kollmannsberger; David F McDermott; William K Oh; Michael B Atkins; Ronald M Bukowski; Brian I Rini; Toni K Choueiri
Journal:  J Clin Oncol       Date:  2009-10-13       Impact factor: 44.544

View more
  8 in total

1.  Metachronous adrenal metastasis from operated contralateral renal cell carcinoma with adrenalectomy and iatrogenic Addison's disease.

Authors:  Hakan Ozturk; Serap Karaaslan
Journal:  Can Urol Assoc J       Date:  2014-09       Impact factor: 1.862

2.  Metastases of Renal Cell Carcinoma to the Contralateral Adrenal Gland Managed by Laparoscopic Adrenalectomy.

Authors:  R B Nerli; S M Patil; Amey Pathade; R A Patil; N D Pingale; P R Malur
Journal:  Indian J Surg Oncol       Date:  2017-05-10

3.  Surgical Management of Local Retroperitoneal Recurrence of Renal Cell Carcinoma after Radical Nephrectomy.

Authors:  Arun Z Thomas; Mehrad Adibi; Leonardo D Borregales; Ly N Hoang; Pheroze Tamboli; Eric Jonasch; Nizar M Tannir; Surena F Matin; Christopher G Wood; Jose A Karam
Journal:  J Urol       Date:  2015-03-07       Impact factor: 7.450

4.  Indications for adrenalectomy during radical nephrectomy for renal cancer.

Authors:  Ahmed H Gabr; Zoe Steinberg; Scott E Eggener; J Stuart Wolf
Journal:  Arab J Urol       Date:  2014-10-22

5.  Incidence of synchronous and metachronous adrenal metastases following tumor nephrectomy in renal cell cancer patients: a retrospective bi-center analysis.

Authors:  Inga Peters; Milan Hora; Thomas R Herrmann; Christoph von Klot; Gerd Wegener; Petr Stransky; Ondrej Hes; Markus A Kuczyk; Axel S Merseburger
Journal:  Springerplus       Date:  2013-07-01

6.  A modified adrenal gland-sparing surgery based on retroperitoneal laparoscopic radical nephrectomy.

Authors:  Zhenyu Xu; Zhengyu Zhang; Jianping Gao; Zhifeng Wei; Xiaofeng Xu; Jie Dong; Hao Tang; Xiaoming Yi; Chaopeng Tang; Wenquan Zhou
Journal:  World J Surg Oncol       Date:  2014-06-05       Impact factor: 2.754

7.  Simultaneous Bilateral Laparoscopic Adrenalectomy for Adrenal Metastases of Renal Cell Carcinoma: A Case Report.

Authors:  Akbar Nouralizadeh; Amir Afyouni; Behnam Shakiba; Fahad Khalid Radhi
Journal:  J Endourol Case Rep       Date:  2017-09-01

8.  Laparoscopic adrenalectomy for metachronous ipsilateral metastasis following nephrectomy for renal cell carcinoma.

Authors:  Petr Stránský; Viktor Eret; Tomáš Urge; Ivan Trávníček; Zdeněk Chudáček; Ondřej Hes; Milan Hora
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2013-03-12       Impact factor: 1.195

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.